Professor Jean-Éric Tarride has been appointed Director of CHEPA, effective May 1, 2017 pending final approval from McMaster’s governing bodies.
The announcement was made March 31 by Dr. Stephen Collins, Associate Dean (Research) for the Faculty of Health Sciences. Tarride succeeds Michel Grignon who was appointed Director in 2011 and continued in an acting role after his five-year term ended last year.
Tarride is an Associate Professor in McMaster's Department of Health Research Methods, Evidence, and Impact (HEI); an Associate Director of the Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe’s Hamilton, St. Joseph’s Healthcare Hamilton; an Associate Member in the Department of Economics at McMaster; and a long-time member of CHEPA.
He has a PhD in Economics from Concordia University in Montreal (2004), an MA in Labour Economics (Toulouse, 1991) and an Honours BA in Econometrics (Toulouse, 1989). His primary research interests are related to the design and conduct of health technology assessments (HTAs) to better inform healthcare policies.
Tarride received in 2007 a Five-Year Career Scientist Award from the Ontario Ministry of Health and Long-Term Care (MOHLTC) and in 2012 the CE&B Departmental Mentoring/Supervision Excellence Award.
He has authored more than 120 peer-reviewed journal articles related to economic evaluations of healthcare technologies and programs.
In addition to his academic experience, Tarride worked for more than 10 years in the pharmaceutical industry in various managerial roles including Director of Health Economics and Reimbursement at AstraZeneca Canada (2012-2014) and Senior Manager, Outcomes Research at Pfizer Canada (2001-2005).
As the new director, Tarride will ensure that CHEPA continues to thrive as a collegial, multi-disciplinary centre of research, maintain its excellent working relationship with the Ontario Ministry of Health and Long-Term Care, and enhance its role as a key source of information for health policymakers while developing new research and funding opportunities with the public and private sectors.